Hypersensitivity reactions induced by proton pump inhibitors: diagnostic and management strategies

03 medical and health sciences 0302 clinical medicine 3. Good health
DOI: 10.26416/aler.7.3.2023.8790 Publication Date: 2023-11-28T08:17:08Z
ABSTRACT
Proton pump inhibitors (PPIs) are highly safe medicines, commonly used as first-line treatment for various digestive diseases. However, the use of PPIs expands, hypersensitivity reactions (HSRs), including both immediate and delayed reactions, have become more prevalent. The most frequent HSR observed in patients treated with is anaphylaxis. Skin tests (prick intradermal) followed by an oral challenge test suggested accurately diagnosing HSRs to PPIs, due their high specificity. It crucial understand patterns cross-reactivity among different establish a therapeutic option evaluate alternative drugs within same class. If patient does not tolerate available options no other equally effective chemically unrelated available, desensitization protocol should be initiated ensure continuous medical treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (22)
CITATIONS (0)